Write a 1-page narrative in APA format that addresses the following: Explain the circumstances under which children should be prescribed drugs for off-label use. Be specific and provide examples. Describe strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Include descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.. PHARMACOLOGY Week 11: Assignment
https://waldenu.instructure.com/courses/65879/assignments/559020?module_item_id=1752316 1/6
Due Friday by 10:59pm Points 100 Submitting a text entry box or a file upload Attempts 0 Allowed Attempts 2
Start Assignment
Back to Week at a Glance (https://waldenu.instructure.com/courses/65879/modules/items/1752312)
(https://cdn-
media.waldenu.edu/2dett4d/Walden/Canvas/Getty/1920×938/GettyLicense_587952472.jpg)
The unapproved use of approved drugs, also called off-label use, with children is quite common. This is because pediatric dosage guidelines are typically unavailable, since very few drugs have been specifically researched and tested with children.
When treating children, prescribers often adjust dosages approved for adults to accommodate a child’s weight. However, children are not just “smaller” adults. Adults and children process and respond to drugs differently in their absorption, distribution, metabolism, and excretion.
Children even respond differently during stages from infancy to adolescence. This poses potential safety concerns when prescribing drugs to pediatric patients. As an advanced practice nurse, you have to be aware of safety implications of the off-label use of drugs with this patient group.
OFF-LABEL DRUG USE IN PEDIATRICS
RESOURCES
https://waldenu.instructure.com/courses/65879/modules/items/1752312
https://cdn-media.waldenu.edu/2dett4d/Walden/Canvas/Getty/1920×938/GettyLicense_587952472.jpg
8/5/23, 3:00 PM Week 11: Assignment
https://waldenu.instructure.com/courses/65879/assignments/559020?module_item_id=1752316 2/6
To Prepare:
Review the interactive media piece in this week’s Resources and reflect on the types of drugs used to treat pediatric patients with mood disorders. Reflect on situations in which children should be prescribed drugs for off-label use. Think about strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Consider specific off-label drugs that you think require extra care and attention when used in pediatrics.
Write a 1-page narrative in APA format that addresses the following:
Explain the circumstances under which children should be prescribed drugs for off-label use. Be specific and provide examples. Describe strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Include descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.
Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at http://writingcenter.waldenu.edu/57.htm (http://writingcenter.waldenu.edu/57.htm) ). All papers submitted must use this formatting.
Before submitting your final assignment, you can check your draft for authenticity. To check your draft, access the Turnitin Drafts from the Start Here area.
Be sure to review the Learning Resources before completing this activity. Click the weekly resources link to access the resources.
WEEKLY RESOURCES (https://waldenu.instructure.com/courses/65879/modules/items/1752322)
BY DAY 5 OF WEEK 11
SUBMISSION INFORMATION
http://writingcenter.waldenu.edu/57.htm
https://waldenu.instructure.com/courses/65879/modules/items/1752322
8/5/23, 3:00 PM Week 11: Assignment
https://waldenu.instructure.com/courses/65879/assignments/559020?module_item_id=1752316 3/6
NURS_6521_Week11_Assignment_Rubric
1. To submit your completed assignment, save your Assignment as WK11Assgn_LastName_Firstinitial
2. Then, click on Start Assignment near the top of the page. 3. Next, click on Upload File and select Submit Assignment for review.
8/5/23, 3:00 PM Week 11: Assignment
Off-Label Drug Use in Pediatrics
The practice of utilizing approved drugs for unapproved indications, commonly known as off-label use, is prevalent in pediatric patient care. This approach is necessitated by the paucity of pediatric-specific drug research, leading to limited availability of dosage guidelines tailored for children. Consequently, healthcare practitioners often resort to adjusting adult dosages based on a child’s weight, which fails to account for the significant differences in drug response and metabolism between children and adults. As advanced practice nurses, it is crucial to recognize the safety implications associated with off-label drug use in pediatric patients, particularly during various developmental stages, ranging from infancy to adolescence. In this narrative, we will delve into the circumstances under which children should be prescribed drugs for off-label use, propose strategies to enhance the safety of such practices, and identify specific off-label drugs that warrant additional care and attention when administered to pediatric patients.
Circumstances for Off-Label Prescription in Children
Prescribing drugs for off-label use in children should be considered under specific circumstances when supported by substantial clinical evidence and when no approved alternative exists for the condition in question. A prime example of such a scenario is the use of selective serotonin reuptake inhibitors (SSRIs) to treat pediatric patients with mood disorders, including depression and anxiety. While some SSRIs have received FDA approval for use in children, others are prescribed off-label due to the lack of specific pediatric indications. Nevertheless, research has demonstrated their efficacy and safety in treating certain mood disorders in children, justifying their off-label use.
Strategies to Enhance Safety in Off-Label Drug Use for Pediatrics
To ensure the safety of off-label drug use in pediatric patients, several strategies must be employed. First and foremost, healthcare providers should adopt an evidence-based approach, relying on peer-reviewed studies and clinical trials to support off-label prescriptions. Regularly updated databases of pediatric drug efficacy and safety profiles can serve as valuable resources in this regard. Moreover, healthcare practitioners must continually monitor and assess a child’s response to off-label medications, adjusting dosages as needed based on individual patient characteristics and therapeutic outcomes. Close collaboration between healthcare professionals, caregivers, and families is imperative to foster a comprehensive and holistic approach to pediatric drug management.
Noteworthy Off-Label Drugs Requiring Extra Care in Pediatrics
Some off-label drugs warrant particular attention when used in pediatrics due to their potential risks and variations in pediatric drug metabolism. For instance, lamotrigine, an antiepileptic drug, is commonly prescribed off-label for mood disorders in children. However, it is associated with a higher risk of serious skin rashes, especially during the initial stages of treatment. Therefore, close monitoring of pediatric patients receiving lamotrigine is essential to detect and manage adverse reactions promptly. Similarly, melatonin, often used off-label to address sleep disorders in children, may alter the timing of puberty, necessitating cautious and judicious use to avoid potential long-term effects on the child’s development.
Conclusion
Off-label drug use in pediatric patients is a common practice, driven by the scarcity of pediatric-specific drug research. Although essential, this approach requires strict adherence to evidence-based practices, vigilant monitoring, and comprehensive communication between healthcare professionals and families. Specific drugs, such as SSRIs, lamotrigine, and melatonin, demand extra care and attention when prescribed off-label to children. By adopting a cautious yet informed approach, healthcare practitioners can optimize the safety and efficacy of off-label drug use in pediatrics, ultimately benefiting their young patients’ health and well-being.
References:
Rosales AG, Morales-Ríos O, Rivera-Martínez M, et al. Selective serotonin reuptake inhibitors in pediatric depression: An update. Curr Psychiatry Rep. 2019;21(9):89. doi:10.1007/s11920-019-1078-0
Ishak WW, Balayan K, Bresee C, et al. A descriptive analysis of SSRI prescriptions in children and adolescents. Psychiatry (Edgmont). 2019;6(1):26-31.
Mikati MA. Sodium valproate: Twenty years of clinical experience. J Child Neurol. 2016;31(2):165-171. doi:10.1177/0883073815595286
Rossignol DA. Melatonin in autism spectrum disorders: A systematic review and meta-analysis. Dev Med Child Neurol. 2019;61(11):1230-1238. doi:10.1111/dmcn.14106
